» Articles » PMID: 18723673

Subclonal Phylogenetic Structures in Cancer Revealed by Ultra-deep Sequencing

Overview
Specialty Science
Date 2008 Aug 30
PMID 18723673
Citations 195
Authors
Affiliations
Soon will be listed here.
Abstract

During the clonal expansion of cancer from an ancestral cell with an initiating oncogenic mutation to symptomatic neoplasm, the occurrence of somatic mutations (both driver and passenger) can be used to track the on-going evolution of the neoplasm. All subclones within a cancer are phylogenetically related, with the prevalence of each subclone determined by its evolutionary fitness and the timing of its origin relative to other subclones. Recently developed massively parallel sequencing platforms promise the ability to detect rare subclones of genetic variants without a priori knowledge of the mutations involved. We used ultra-deep pyrosequencing to investigate intraclonal diversification at the Ig heavy chain locus in 22 patients with B-cell chronic lymphocytic leukemia. Analysis of a non-polymorphic control locus revealed artifactual insertions and deletions resulting from sequencing errors and base substitutions caused by polymerase misincorporation during PCR amplification. We developed an algorithm to differentiate genuine haplotypes of somatic hypermutations from such artifacts. This proved capable of detecting multiple rare subclones with frequencies as low as 1 in 5000 copies and allowed the characterization of phylogenetic interrelationships among subclones within each patient. This study demonstrates the potential for ultra-deep resequencing to recapitulate the dynamics of clonal evolution in cancer cell populations.

Citing Articles

Analysis of Shared Variants between Cancer Biospecimens.

Foote M, White J, Chatila W, Argiles G, Lu S, Rousseau B Clin Cancer Res. 2024; 31(2):376-386.

PMID: 39561276 PMC: 11747808. DOI: 10.1158/1078-0432.CCR-24-1583.


The roles of patient-derived xenograft models and artificial intelligence toward precision medicine.

Janitri V, Aruljothi K, Ravi Mythili V, Singh S, Prasher P, Gupta G MedComm (2020). 2024; 5(10):e745.

PMID: 39329017 PMC: 11424683. DOI: 10.1002/mco2.745.


Resolving tumor evolution: a phylogenetic approach.

Li L, Xie W, Zhan L, Wen S, Luo X, Xu S J Natl Cancer Cent. 2024; 4(2):97-106.

PMID: 39282584 PMC: 11390690. DOI: 10.1016/j.jncc.2024.03.001.


B cell receptor repertoire abnormalities in autoimmune disease.

Yuuki H, Itamiya T, Nagafuchi Y, Ota M, Fujio K Front Immunol. 2024; 15:1326823.

PMID: 38361948 PMC: 10867955. DOI: 10.3389/fimmu.2024.1326823.


A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data.

Qiao Y, Huang X, Moos P, Ahmann J, Pomicter A, Deininger M Genome Res. 2024; 34(1):94-105.

PMID: 38195207 PMC: 10903947. DOI: 10.1101/gr.278234.123.


References
1.
Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G . Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res. 2005; 65(17):7591-5. DOI: 10.1158/0008-5472.CAN-05-1855. View

2.
Hoffmann C, Minkah N, Leipzig J, Wang G, Arens M, Tebas P . DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res. 2007; 35(13):e91. PMC: 1934997. DOI: 10.1093/nar/gkm435. View

3.
Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer R . Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007; 17(8):1195-201. PMC: 1933516. DOI: 10.1101/gr.6468307. View

4.
Foster P . Methods for determining spontaneous mutation rates. Methods Enzymol. 2006; 409:195-213. PMC: 2041832. DOI: 10.1016/S0076-6879(05)09012-9. View

5.
van Dongen J, Langerak A, Bruggemann M, Evans P, Hummel M, Lavender F . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17(12):2257-317. DOI: 10.1038/sj.leu.2403202. View